NEW
YORK, July 18, 2024 /PRNewswire/ -- The global
blood-grouping reagents market size is estimated to grow by
USD 520.68 million from 2024-2028,
according to Technavio. The market is estimated to grow at a CAGR
of 8.13% during the forecast
period. Increasing prevalence of chronic
disorders is driving market growth, with a trend
towards advancements in diagnostic devices.
However, risks associated with blood transfusion poses a
challenge. Key market players include AliveDX, Arena Bio Scien,
ARKRAY Inc., Atlas Medical GmbH, BAG Health Care GmbH, Bio Rad
Laboratories Inc., Calibre Scientific Inc., Danaher Corp., DIAGAST
SAS, Grifols SA, Merck KGaA, Novacyt SA, QuidelOrtho Corp., Rapid
Labs Ltd., Thermo Fisher Scientific Inc., Torax Biosciences Ltd.,
Tulip Diagnostics Pvt. Ltd., Fortress Diagnostics, Paragon Care
Ltd., and VitroScient.
Get a detailed analysis on regions, market
segments, customer landscape, and companies - Click for the
snapshot of this report
Forecast
period
|
2024-2028
|
Base Year
|
2023
|
Historic
Data
|
2018 - 2022
|
Segment
Covered
|
End-user (Hospitals and
blood banks, Clinical laboratories, and Academic and research
institutes), Technique (PCR-based and microarray techniques,
Assay-based techniques, Massively parallel sequencing techniques,
and Serology), and Geography (North America, Europe, Asia, and Rest
of World (ROW))
|
Region
Covered
|
North America, Europe,
Asia, and Rest of World (ROW)
|
Key companies
profiled
|
AliveDX, Arena Bio
Scien, ARKRAY Inc., Atlas Medical GmbH, BAG Health Care GmbH, Bio
Rad Laboratories Inc., Calibre Scientific Inc., Danaher Corp.,
DIAGAST SAS, Grifols SA, Merck KGaA, Novacyt SA, QuidelOrtho Corp.,
Rapid Labs Ltd., Thermo Fisher Scientific Inc., Torax Biosciences
Ltd., Tulip Diagnostics Pvt. Ltd., Fortress Diagnostics, Paragon
Care Ltd., and VitroScient
|
Key Market Trends Fueling Growth
The healthcare industry's diagnostic devices sector is
experiencing technological advancements, enhancing diagnostic
adherence and delivering swift, accurate results. Molecular typing,
an innovative blood-grouping method, detects polymorphisms and
mutations controlling antigen expression, predicting probable
antigens to prevent adverse reactions. Techniques like column
agglutination, solid-phase red cell adherence assay, and
erythrocyte magnetized technique, as well as automated microplate
systems, improve testing quality and accuracy. Traditional
serological methods struggle to precisely identify clinically
significant variant antigens, making molecular typing essential for
managing diseases like sickle cell anemia. Automated blood group
typing products minimize human errors, reducing transfusion risks
and increasing market demand. Technological innovations are set to
boost the global blood-grouping reagents market growth.
The Blood-Grouping Reagents market is witnessing significant
growth due to the increasing demand for blood group typing in
various applications. Antigens and antibodies play a crucial role
in this process, with Rh factor being a key antigen. Ortho Clinical
Diagnostics is a major player in this market, providing solutions
for blood group typing and antibody screening. Blood banks require
large inventories of consumables and instruments for blood donation
and transfusions, especially in emergencies caused by accidents or
chronic diseases like anemia, haemophilia, and blood cancers.
Serology and assay-based techniques are popular methods for blood
sample analysis, with companies like Arena BioScience offering kits
and test types. Hospitals use these reagents for cross-matching
tests, HLA typing, and ABO and antigen typing. The ageing
population and forecasting analysis drive market growth, with
advanced technologies like artificial intelligence, PCR-based and
microarray, and massively parallel sequencing being adopted for
inventory management and blood safety.
Discover 360° analysis of this market. For
complete information, schedule your consultation- Book
Here!
Market Challenges
- Blood transfusions are essential for replacing lost blood due
to surgeries, injuries, or chemotherapy. However, they come with
risks such as acute and delayed hemolytic reactions, allergic
responses, and iron overload. These complications can restrict
blood transfusions and negatively impact the demand for
blood-grouping reagents, which are crucial for ensuring a
compatible blood match. The global blood-grouping reagents market
may experience a decline in growth due to these factors during the
forecast period. Blood-grouping reagents play a vital role in
ensuring the safety and effectiveness of blood transfusions by
identifying the blood type of donors and recipients. The risks and
complications associated with blood transfusions, therefore, pose a
challenge to the growth of this market.
- The Blood-Grouping Reagents market is experiencing significant
growth due to increasing healthcare expenditure and the rising
number of surgical procedures, organ transplantations, and blood
transfusions. However, challenges such as Haemophilia and blood
cancers require advanced testing methods like Assay-Based
Techniques and PCR-based and Microarray. Inventory management is
crucial due to the perishable nature of serological fluids and
consumables. Companies like Arena BioScience are innovating with
Artificial Intelligence for forecasting analysis. The aging
population and chronic disorders drive the demand for ABO blood
tests, antibody screening, HLA typing, cross-matching tests, and
antigen typing. Expansion strategies include offering a wide range
of test types, from ABO blood tests to massively parallel
sequencing. Regional level analysis is essential for understanding
market trends and catering to diverse needs.
For more insights on driver and
challenges - Download a Sample Report
Segment Overview
This blood-grouping reagents market report extensively covers
market segmentation by
- End-user
- 1.1 Hospitals and blood banks
- 1.2 Clinical laboratories
- 1.3 Academic and research institutes
- Technique
- 2.1 PCR-based and microarray techniques
- 2.2 Assay-based techniques
- 2.3 Massively parallel sequencing techniques
- 2.4 Serology
- Geography
- 3.1 North America
- 3.2 Europe
- 3.3 Asia
- 3.4 Rest of World (ROW)
1.1 Hospitals and blood banks- The hospitals and
blood banks segment dominates the global blood-grouping reagents
market due to the high demand for these reagents in healthcare
facilities. Rapid testing procedures, such as rapid blood-grouping
tests, are increasingly used in emergency departments and intensive
care units to determine blood types quickly, reducing waiting times
and improving patient care. The development of advanced
blood-grouping technologies, like the paper-based test for
SARS-CoV-2 neutralizing antibodies, further enhances the market's
growth. Hospitals and clinics have been establishing in-house
laboratories to cater to the rising number of critical and
emergency cases, increasing the demand for rapid blood-grouping
products. Additionally, social media platforms, such as Facebook,
have played a significant role in increasing blood donations and
the subsequent need for blood-grouping tests. These factors
collectively contribute to the significant growth of the global
blood-grouping reagents market.
For more information on market segmentation with
geographical analysis including forecast (2024-2028) and historic
data (2018 - 2022) - Download a Sample Report
Learn and explore more about Technavio's in-depth research
reports
The global biotechnology reagents market is experiencing robust
growth driven by advancements in biopharmaceuticals and genetic
engineering. Key players are innovating with specialized reagents
for DNA sequencing, PCR, and cell culture applications, enhancing
research efficiency and accuracy.
The market for molecular biology enzymes, kits, and reagents is
expanding rapidly, supported by increasing demand for personalized
medicine and genetic testing. Innovations in enzyme technology and
PCR kits are driving market growth, catering to research and
clinical diagnostics needs worldwide.
The affinity chromatography reagents market is growing due to
rising applications in pharmaceutical and biotechnology research.
High specificity and purification efficiency of these reagents for
protein separation are fueling their adoption, particularly in drug
development and bioprocessing sectors globally.
Research Analysis
The Blood-Grouping Reagents market refers to the supply of
antigens and antibodies used for blood group typing,
cross-matching, and other related tests. These reagents play a
crucial role in identifying the ABO blood group and Rh factor in
donated blood, ensuring its safety for transfusions and
transplantation procedures. Chronic diseases, accidents, and blood
donation are significant applications driving the demand for
blood-grouping reagents. The market encompasses various
technologies, including assay-based, PCR-based and Microarray,
Massively Parallel Sequencing, Antibody Screening, HLA Typing, and
Cross-matching Tests. Hospitals and Blood Banks are the primary
end-users, with the need for inventory management and stringent
blood safety regulations further fueling market growth. Red blood
cells, antigens, and antibodies are essential components of
blood-grouping reagents, enabling accurate blood typing for various
medical applications.
Market Research Overview
The Blood-Grouping Reagents market is driven by the increasing
demand for blood group typing in various medical applications,
including blood transfusions, surgical procedures, organ
transplantation, and blood donation. Blood group typing is
essential for ensuring blood safety and compatibility in
transfusions, preventing transfusion reactions and other
complications. Antigens and antibodies are the key components of
blood-grouping reagents, with the Rh factor being a significant
antigen. The market includes assay-based techniques such as
serology, PCR-based and microarray, massively parallel sequencing,
and antibody screening for HLA typing and cross-matching tests. The
market is influenced by factors such as the aging population,
chronic diseases like anemia, haemophilia, and blood cancers,
healthcare expenditure, and inventory management. Consumables and
instruments are the major product segments, with kits and test
types including ABO blood tests, antibody screening, HLA typing,
and cross-matching tests. The market is forecasted to grow due to
expansion strategies, regional level analysis, and advancements in
technology such as artificial intelligence and cross-matching.
Blood banks, hospitals, and healthcare facilities are the primary
end-users, with applications in blood transfusion, transplantation
procedures, and blood sample analysis.
Table of Contents:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation
- End-user
-
- Hospitals And Blood Banks
- Clinical Laboratories
- Academic And Research Institutes
- Technique
-
- PCR-based And Microarray Techniques
- Assay-based Techniques
- Massively Parallel Sequencing Techniques
- Serology
- Geography
-
- North America
- Europe
- Asia
- Rest Of World (ROW)
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix
About Technavio
Technavio is a leading global technology research and advisory
company. Their research and analysis focuses on emerging market
trends and provides actionable insights to help businesses identify
market opportunities and develop effective strategies to optimize
their market positions.
With over 500 specialized analysts, Technavio's report library
consists of more than 17,000 reports and counting, covering 800
technologies, spanning across 50 countries. Their client base
consists of enterprises of all sizes, including more than 100
Fortune 500 companies. This growing client base relies on
Technavio's comprehensive coverage, extensive research, and
actionable market insights to identify opportunities in existing
and potential markets and assess their competitive positions within
changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
View original content to download
multimedia:https://www.prnewswire.com/news-releases/blood-grouping-reagents-market-size-is-set-to-grow-by-usd-520-68-million-from-2024-2028--increasing-prevalence-of-chronic-disorders-to-boost-the-market-growth-technavio-302199157.html
SOURCE Technavio